Login to Your Account



Endocyte stakes future on smaller pipeline, focus on 'promising programs'

By Marie Powers
News Editor

Friday, June 2, 2017

Although halting one clinical program, modifying another and axing 40 percent of its staff wasn't exactly the way Endocyte Inc. hoped to make its entrance at the ASCO annual meeting in Chicago, those were precisely the steps the company took to "put patients first."

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription